The Journey Towards Solubility Assessment of Small Molecules Using HPLC-DAD - Centre de recherche en cancérologie de Lyon (UMR INSERM 1052 ; CNRS 5286 ; Centre Léon Bérard) Accéder directement au contenu
Communication Dans Un Congrès Année : 2022

The Journey Towards Solubility Assessment of Small Molecules Using HPLC-DAD

Résumé

Through the process of developing bioactive small molecules, solubility determination is a crucial step. Many research papers treating problems related to solubility are published, but none of them fully describes the methods and steps for solubility assessment. In addition, in silico prediction tools and databases, such as SwissADME, ACD/Percepta, DrugBank and many others offer the possibility to have approximative solubility values based on the structure of the molecule. Although, significant differences can be observed depending on the database and the conditions of the experiment: solvent, pH, temperature… etc. The lack of data can be a barrier to obtaining details on solubility measurement methods. This presentation aims to describe, step by step, the journey of theophylline solubility determination using HPLC-DAD.
slides 13143-Nov1-30-2022.pdf (2.03 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03840347 , version 1 (05-11-2022)

Identifiants

Citer

Nada Hemmani, Anaïs Cacilie Martin, Andy Larivière, Mathis Tresallet, Kensa Tchang, et al.. The Journey Towards Solubility Assessment of Small Molecules Using HPLC-DAD. 8th International Electronic Conference on Medicinal Chemistry, Nov 2022, Basel (on line), Switzerland. ⟨10.3390/ECMC2022-13143⟩. ⟨hal-03840347⟩
21 Consultations
12 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More